Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Monocyte-to-macrophage differentiation is a critical event that accentuates atherosclerosis by promoting an inflammatory environment within the vessel wall. In this study, we investigated the molecular mechanisms responsible for monocyte-to-macrophage differentiation and, subsequently, the effect of metformin in regressing angiotensin II (Ang-II)-mediated atheromatous plaque formation in ApoE−/− mice. AMPK activity was dose and time dependently downregulated during phorbol myristate acetate (PMA)-induced monocyte-to-macrophage differentiation, which was accompanied by an upregulation of proinflammatory cytokine production. Of note, AMPK activators metformin and AICAR significantly attenuated PMA-induced monocyte-to-macrophage differentiation and proinflammatory cytokine production. However, inhibition of AMPK activity alone by compound C was ineffective in promoting monocyte-to-macrophage differentiation in the absence of PMA. On the other hand, inhibition of c-Jun N-terminal kinase activity inhibited PMA-induced inflammation but not differentiation, suggesting that inflammation and differentiation are independent events. In contrast, inhibition of STAT3 activity inhibited both inflammation and monocyte-to-macrophage differentiation. By decreasing STAT3 phosphorylation, metformin and AICAR through increased AMPK activation caused inhibition of monocyte-to-macrophage differentiation. Metformin attenuated Ang-II–induced atheromatous plaque formation and aortic aneurysm in ApoE−/− mice partly by reducing monocyte infiltration. We conclude that the AMPK-STAT3 axis plays a pivotal role in regulating monocyte-to-macrophage differentiation and that by decreasing STAT3 phosphorylation through increased AMPK activity, AMPK activators inhibit monocyte-to-macrophage differentiation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A working model of metformin’s anti-inflammatory properties also suggests that metformin, in an AMPK-dependent inhibition of STAT3, prevents the differentiation of monocytes to macrophages”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Vasamsetti et al. 2015
Citations
Cites
1 retracted
Activation of Protein Phosphatase 2A by Palmitate Inhibits AMP-activated Protein Kinase
Wu, Y., Song, P., Xu, J., Zhang, M., & Zou, M.-H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608310200 · Cited by 274 · cited 1×
“AMPK-mediated signaling events are downregulated by lipopolysaccharides (LPSs), free fatty acids, high-fat diets, and lipid infusion in macrophages and endothelial cells (12,13).”
BackgroundRetractedRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“Earlier studies showed that the pleiotropic effects of metformin are partly mediated by the activation of AMPK (7,8).”
BackgroundAMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602 · cited 2×
“AMPK functions as a fuel gauge, sensing the changes in the energy status of the cell and, thus, playing a critical role in regulating systemic energy balance (9,10).”
BackgroundKahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · cited 1×
“AMPK functions as a fuel gauge, sensing the changes in the energy status of the cell and, thus, playing a critical role in regulating systemic energy balance (9,10).”
BackgroundMacrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669 · cited 3×
“a diverse repertoire of inflammatory mediators (2).”
BackgroundThe immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182 · cited 3×
“Substantial evidence implicates that macrophages are abundantly present at all stages of atherosclerotic disease process (1).”
InfluentialPPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637 · cited 1×
“AMPK activity in the blood is predominantly located in monocytes and lymphocytes as the 1a isoform (25), and a reduction in AMPK activity is associated with various pathophysiological effects (26).”
Background
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
The mechanisms of action of metformin
Rena, G., Hardie, D. G., & Pearson, E. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4342-z · Cited by 2,287
“Metformin has, for example, been shown to have direct effects on inflammation, including effects on NF-κB signalling and differentiation of monocytes into macrophages [52, 53], as well as suppressing proinflammatory cytokines from these macrophages.”
BackgroundThe Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Tsalamandris, S., Antonopoulos, A. S., Oikonomou, E., Papamikroulis, G.-A., Vogiatzi, G., Papaioannou, S., Deftereos, S., & Tousoulis, D. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.33.1 · Cited by 1,381
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Abdominal aortic aneurysm: update on pathogenesis and medical treatments
Golledge, J. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0114-9 · Cited by 788
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
“A working model of metformin’s anti-inflammatory properties also suggests that metformin, in an AMPK-dependent inhibition of STAT3, prevents the differentiation of monocytes to macrophages (Vasamsetti et al. 2015).”
BackgroundBhatti, J. S., Sehrawat, A., Mishra, J., Sidhu, I. S., Navik, U., Khullar, N., Kumar, S., Bhatti, G. K., & Reddy, P. H. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.019 · Cited by 693
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Foretz, M., Guigas, B., & Viollet, B. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0242-2 · Cited by 686
AMPK as a Therapeutic Target for Treating Metabolic Diseases
Day, E. A., Ford, R. J., & Steinberg, G. R. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.05.004 · Cited by 619
Deng, Z., Rong, Y., Teng, Y., Mu, J., Zhuang, X., Tseng, M., Samykutty, A., Zhang, L., Yan, J., Miller, D., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.01.025 · Cited by 488
Wang, Q., Zhang, M., Torres, G., Wu, S., Ouyang, C., Xie, Z., & Zou, M.-H. (2017) · Diabetes · doi:10.2337/db16-0915 · Cited by 370
“In addition, metformin attenuates the high-fat diet– or angiotensin II–induced formation of atheromatous plaques by downregulating the angiotensin II receptor and reducing monocyte-to-macrophage differentiation (40,41).”
BackgroundPetrie, J. R., Chaturvedi, N., Ford, I., Brouwers, M. C. G. J., Greenlaw, N., Tillin, T., Hramiak, I., Hughes, A. D., Jenkins, A. J., Klein, B. E. K., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30194-8 · Cited by 357
“22 Moreover, metformin can improve aspects of endothelial function 23 and inhibit formation of advanced glycation end products by binding and inactivating methylglyoxal via an AMPK-independent pathway.”
Macrophage functions in lean and obese adipose tissue
Thomas, D., & Apovian, C. (2017) · Metabolism · doi:10.1016/j.metabol.2017.04.005 · Cited by 316
Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis
Kimura, Y., Tsukui, D., & Kono, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212394 · Cited by 309
“In a study on the pathogenesis of atherosclerosis, activation of AMPK suppressed the development of atherosclerosis in ApoE-KO mice [72,73].”
BackgroundHan, J. H., Oh, T. J., Lee, G., Maeng, H. J., Lee, D. H., Kim, K. M., Choi, S. H., Jang, H. C., Lee, H. S., Park, K. S., et al. (2017) · Diabetologia · doi:10.1007/s00125-016-4158-2 · Cited by 281
“In contrast, metformin attenuated angiotensin-II-induced atheromatous plaque formation in ApoE mice [49].”
BackgroundAnti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications
Pollack, R. M., Donath, M. Y., LeRoith, D., & Leibowitz, G. (2016) · Diabetes Care · doi:10.2337/dcs15-3015 · Cited by 262
“in monocytes and macrophages and inhibit monocyte-to-macrophage differentiation (37).”
BackgroundHou, P.-P., Luo, L.-J., Chen, H.-Z., Chen, Q.-T., Bian, X.-L., Wu, S.-F., Zhou, J.-X., Zhao, W.-X., Liu, J.-M., Wang, X.-M., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.004 · Cited by 253
Metformin and Systemic Metabolism
He, L. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.09.001 · Cited by 235
“Interestingly, suprapharmacological metformin prevents monocyte-to-macrophage differentiation via AMPK activation to reduce the production of proinflammatory cytokines and promote the macrophage polarization to anti-inflammatory functional M2 phenotypes [94].”
BackgroundMetformin improves obesity-associated inflammation by altering macrophages polarization
Jing, Y., Wu, F., Li, D., Yang, L., Li, Q., & Li, R. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.025 · Cited by 224
Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease
Matoba, K., Takeda, Y., Nagai, Y., Kawanami, D., Utsunomiya, K., & Nishimura, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143393 · Cited by 223
“By activating AMPK, metformin disrupts the phosphorylation of STAT signaling and attenuates the differentiation of monocytes into macrophages [73].”
BackgroundTargeting immune dysfunction in aging
Borgoni, S., Kudryashova, K. S., Burka, K., & de Magalhães, J. P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101410 · Cited by 223
Nesti, L., & Natali, A. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.04.009 · Cited by 211
Apostolova, N., Iannantuoni, F., Gruevska, A., Muntane, J., Rocha, M., & Victor, V. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101517 · Cited by 197
“Metformin has also been shown to have direct effects on inflammation [107]; it acts on NF-κB signalling and differentiation of monocytes into macrophages [108] and is able to suppress several inflammatory cytokines in the plasma of non-diabetic individuals [109].”
BackgroundMetformin and Autoimmunity: A “New Deal” of an Old Drug
Ursini, F., Russo, E., Pellino, G., D’Angelo, S., Chiaravalloti, A., De Sarro, G., Manfredini, R., & De Giorgio, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01236 · Cited by 194
“In THP-1 acute monocytic leukemia cell line, metformin treatment abrogates phorbol 12-myristate 13-acetateinduced monocyte-to-macrophage differentiation and IL-1β, TNF-α, and MCP-1 production (78).”
BackgroundSalt, I. P., & Hardie, D. G. (2017) · Circulation Research · doi:10.1161/circresaha.117.309633 · Cited by 187
Immunosenescence: signaling pathways, diseases and therapeutic targets
Fu, Y., Wang, B., Alu, A., Hong, W., Hong, L., He, X., Shi, H., Cheng, P., & Yang, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02371-z · Cited by 187
“416 Pharmacological intervention through p38-MAPK signaling pathway inhibition or COX-2 suppression has demonstrated ef fi cacy in restoring monocyte functional competence.”
Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
Goldfine, A. B., & Shoelson, S. E. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88884 · Cited by 172
“The antiinflammatory actions of metformin appear to be independent of glycemia (58, 78, 79) and are most prominent in immune cells and vascular tissues (53, 54, 74, 80, 81).”
Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control
Scheen, A. J., Esser, N., & Paquot, N. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.02.003 · Cited by 171
“[21] Vasamsetti SB, Karnewar S, Kanugula AK, Raj AT, Kumar JM, Kotam-”
BackgroundTargeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis
Chen, Q., Lv, J., Yang, W., Xu, B., Wang, Z., Yu, Z., Wu, J., Yang, Y., & Han, Y. (2019) · Theranostics · doi:10.7150/thno.35528 · Cited by 169
“Thus, monocyte-tomacrophage differentiation is a critical event that accentuates atherosclerosis by promoting an inflammatory environment within the vessel wall [103].”
BackgroundMitochondrial Dysfunction in Atherosclerosis
Peng, W., Cai, G., Xia, Y., Chen, J., Wu, P., Wang, Z., Li, G., & Wei, D. (2019) · DNA and Cell Biology · doi:10.1089/dna.2018.4552 · Cited by 166
“Moreover, the differentiation of monocytes into macrophages was inhibited by metformin administration in ApoE - / - mice (Vasamsetti et al. , 2015).”
Kimura, Y., Yanagida, T., Onda, A., Tsukui, D., Hosoyamada, M., & Kono, H. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313224 · Cited by 165
Metformin, Macrophage Dysfunction and Atherosclerosis
Feng, X., Chen, W., Ni, X., Little, P. J., Xu, S., Tang, L., & Weng, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.682853 · Cited by 164
Metformin treatment status and abdominal aortic aneurysm disease progression
Fujimura, N., Xiong, J., Kettler, E. B., Xuan, H., Glover, K. J., Mell, M. W., Xu, B., & Dalman, R. L. (2016) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2016.02.020 · Cited by 163
“aneurysms develop after subcutaneous delivery of angiotensin II in apolipoprotein E-deficient mice, metformin therapy was also noted to reduce AAA diameter enlargement and histologic disease progression, reducing concern that the present findings are model-specific and increasing the generalizability of the current re…”
Luo, F., Das, A., Chen, J., Wu, P., Li, X., & Fang, Z. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0860-y · Cited by 163
Teodoro, J. S., Nunes, S., Rolo, A. P., Reis, F., & Palmeira, C. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01857 · Cited by 164
Mechanisms of Macrophage Polarization in Insulin Signaling and Sensitivity
Orliaguet, L., Dalmas, E., Drareni, K., Venteclef, N., & Alzaid, F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00062 · Cited by 144
Karnewar, S., Neeli, P. K., Panuganti, D., Kotagiri, S., Mallappa, S., Jain, N., Jerald, M. K., & Kotamraju, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.018 · Cited by 161
Self-citationMetformin: A Novel Weapon Against Inflammation
Bai, B., & Chen, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.622262 · Cited by 161
“The phosphorylation of signal transducer and activator of transcription 3 (STAT3) plays a critical role in mediating monocyte-to-macrophage differentiation and inflammation, but all of which are dosedependently inhibited by metformin (Vasamsetti et al., 2015).”
BackgroundXue, C., Chen, K., Gao, Z., Bao, T., Dong, L., Zhao, L., Tong, X., & Li, X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-022-01016-w · Cited by 162
“Under the regulation of the AMPK-STAT3 axis, chemokines MCP-1 and CCR2 recruit circulating monocytes and M1-like differentiated macrophages to adhere to ECs in the vessel wall, accelerating metabolic disorders [103–105].”
BackgroundThe effects of monocytes on tumor cell extravasation in a 3D vascularized microfluidic model
Boussommier-Calleja, A., Atiyas, Y., Haase, K., Headley, M., Lewis, C., & Kamm, R. D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.005 · Cited by 158
Zhou, Z., Tang, Y., Jin, X., Chen, C., Lu, Y., Liu, L., & Shen, C. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4847812 · Cited by 127
Metformin as an anti-inflammatory agent: a short review
Kristófi, R., & Eriksson, J. W. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0194 · Cited by 156
“Similarly, plaque formation in the metformin-treated animals was attenuated, with reduced monocyte infiltration (Vasamsetti et al. 2015).”
BackgroundIncio, J., Suboj, P., Chin, S. M., Vardam-Kaur, T., Liu, H., Hato, T., Babykutty, S., Chen, I., Deshpande, V., Jain, R. K., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0141392 · Cited by 144
Sanches-Silva, A., Testai, L., Nabavi, S. F., Battino, M., Pandima Devi, K., Tejada, S., Sureda, A., Xu, S., Yousefi, B., Majidinia, M., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104626 · Cited by 135
Goldberg, R. B., Aroda, V. R., Bluemke, D. A., Barrett-Connor, E., Budoff, M., Crandall, J. P., Dabelea, D., Horton, E. S., Mather, K. J., Orchard, T. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.025483 · Cited by 137
“(25), inhibition of vascular senescence, and down-regulation of angiotensin II type 1 receptors by gest on M ay (2)9, 2017 http://ciajournals.”
BackgroundAssociation between metformin prescription and growth rates of abdominal aortic aneurysms
Golledge, J., Moxon, J. V., Pinchbeck, J. L., Anderson, G., Rowbotham, S. E., Jenkins, J. S., Bourke, M., Bourke, B. M., Dear, A. E., Buckenham, T. M., et al. (2017) · British journal of surgery · doi:10.1002/bjs.10587 · Cited by 142
Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Cheng, D., Xu, Q., Wang, Y., Li, G., Sun, W., Ma, D., Zhou, S., Liu, Y., Han, L., & Ni, C. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03036-5 · Cited by 142
Hasanvand, A. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-00980-6 · Cited by 125
Wu, D., Ren, P., Zheng, Y., Zhang, L., Xu, G., Xie, W., Lloyd, E. E., Zhang, S., Zhang, Q., Curci, J. A., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307648 · Cited by 123
mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors
Wu, T., Zhao, Y., Wang, H., Li, Y., Shao, L., Wang, R., Lu, J., Yang, Z., Wang, J., & Zhao, Y. X. (2016) · Scientific Reports · doi:10.1038/srep20250 · Cited by 121
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Cao, R. Y., Tian, H., Zhang, Y., Liu, G., Xu, H., Rao, G., Tian, Y., & Fu, X. (2023) · MedComm · doi:10.1002/mco2.283 · Cited by 108
Long-term activation of the innate immune system in atherosclerosis
Christ, A., Bekkering, S., Latz, E., & Riksen, N. P. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.04.004 · Cited by 93
“In addition, metformin inhibited monocyte to macrophage differentiation, and reduced pro-inflammatory cytokine production [109].”
BackgroundInflammation as A Precursor of Atherothrombosis, Diabetes and Early Vascular Aging
Barbu, E., Popescu, M.-R., Popescu, A.-C., & Balanescu, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020963 · Cited by 107
Metformin and its anti-inflammatory and anti-oxidative effects; new concepts
Dehkordi, A. H., Abbaszadeh, A., Mir, S., & Hasanvand, A. (2018) · Journal of Renal Injury Prevention · doi:10.15171/jrip.2019.11 · Cited by 105
“By reducing the phosphorylation of signal transducer and activator of transcription (STAT) through increasing the activation of AMPK, metformin inhibits the differentiation of monocyte into macrophages (15).”
BackgroundYang, M., Lv, H., Liu, Q., Zhang, L., Zhang, R., Huang, X., Wang, X., Han, B., Hou, S., Liu, D., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9173530 · Cited by 105
The Role and Mechanism of Metformin in Inflammatory Diseases
Lin, H., Ao, H., Guo, G., & Liu, M. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s436147 · Cited by 105
“35 Collectively, evidence suggested that metformin exerts remarkable anti-inflammatory and immunosuppressive effects in inflammatory/autoimmune models.”
Szymczak-Pajor, I., Wenclewska, S., & Śliwińska, A. (2022) · Pharmaceuticals · doi:10.3390/ph15070810 · Cited by 101
Qin, M., Luo, Y., Meng, X., Wang, M., Wang, H., Song, S.-Y., Ye, J., Pan, R., Yao, F., Wu, P., et al. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.03.002 · Cited by 99
Moussa, G., Alaaeddine, R. A., Alaeddine, L. M., Nassra, R. A., Belal, A. S. F., Ismail, A. E., EL‐Yazbi, A. F., Abdel‐Ghany, Y. S., & Hazzaa, A. A. B. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.12.065 · Cited by 98
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects
Salvatore, T., Pafundi, P. C., Galiero, R., Rinaldi, L., Caturano, A., Vetrano, E., Aprea, C., Albanese, G., Di Martino, A., Ricozzi, C., et al. (2020) · Biomedicines · doi:10.3390/biomedicines9010003 · Cited by 97
“Incidentally, the drug also prevented monocyte differentiation into macrophages and foam cell, a process that metformin regulates via AMPK-mediated inhibition of STAT3 activation [195].”
BackgroundMetformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis
Qin, G., Lian, J., Huang, L. J., Zhao, Q., Liu, S., Zhang, Z., Chen, X., Yue, D., Li, L., Li, F., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1442167 · Cited by 97
Ferulic Acid Ameliorates Atherosclerotic Injury by Modulating Gut Microbiota and Lipid Metabolism
Gu, Y., Zhang, Y., Li, M., Huang, Z., Jiang, J., Chen, Y., Chen, J., Jia, Y., Zhang, L., & Zhou, F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.621339 · Cited by 96
“Additionally, some studies have reported that AMPK activators suppressed atherosclerotic plaque size by reducing arterial deposition of excess lipids (Vasamsetti et al., 2015; Kimura et al., 2020).”
BackgroundMetformin in therapeutic applications in human diseases: its mechanism of action and clinical study
Du, Y., Zhu, Y., Zhou, Y., Ding, J., & Liu, J. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00108-w · Cited by 96
Mechanisms of action of metformin with special reference to cardiovascular protection
Zilov, A. V., Abdelaziz, S. I., Alshammary, A., Zahrani, A. A., Amir, A., Khalil, S. H. A., Brand, K. M. G., Elkafrawy, N., Hassoun, A. A. K., Jahed, S. A., et al. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3173 · Cited by 94
Metformin alleviates inflammation through suppressing FASN-dependent palmitoylation of Akt
Xiong, W., Sun, K., Zhu, Y., Zhang, X., Zhou, Y., & Zou, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04235-0 · Cited by 94
“Therefore, we preliminarily detected the phosphorylation levels of AMPK in macrophages.”
BackgroundInfluentialAcetaldehyde dehydrogenase 2 interactions with LDLR and AMPK regulate foam cell formation
Zhong, S., Li, L., Zhang, Y., Zhang, L., Lu, J., Guo, S., Liang, N., Ge, J., Zhu, M., Tao, Y., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci122064 · Cited by 92
“AMPK activators metformin and AICAR inhibited monocyte-to-macrophage differentiation through AMPK-mediated inhibition of STAT3 activation (36).”
Diabetes Mellitus: Is It Protective against Aneurysm? A Narrative Review
Patel, K., Zafar, M. A., Ziganshin, B. A., & Elefteriades, J. A. (2018) · Cardiology · doi:10.1159/000490373 · Cited by 91
Quercetin Inhibits LPS-Induced Inflammation and ox-LDL-Induced Lipid Deposition
Xue, F., Nie, X., Shi, J., Liu, Q., Wang, Z., Li, X., Zhou, J., Su, J., Xue, M., Chen, W., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00040 · Cited by 91
“Moreover, decreasing the phosphorylation of STAT3 suppressed both inflammation and monocyte-to-macrophage differentiation (Vasamsetti et al., 2015).”
BackgroundThe multifaceted effects of metformin on tumor microenvironment
Kurelac, I., Umesh Ganesh, N., Iorio, M., Porcelli, A. M., & Gasparre, G. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.010 · Cited by 81
Clinical approach to the inflammatory etiology of cardiovascular diseases
Ruscica, M., Corsini, A., Ferri, N., Banach, M., & Sirtori, C. R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104916 · Cited by 89
“In the vascular endothelium, metformin inhibits monocyte-to-macrophage differentiation [175].”
Elzahhar, P. A., Wahab, S. M. A. E., Elagawany, M., Daabees, H. G., Belal, A. S. F., EL‐Yazbi, A. F., Eid, A. H., Alaaeddine, R. A., Hegazy, R. R., Allam, R. M., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112439 · Cited by 89
Pleiotropic Benefits of Metformin: Macrophage Targeting Its Anti-inflammatory Mechanisms
Hattori, Y., Hattori, K., & Hayashi, T. (2015) · Diabetes · doi:10.2337/db15-0090 · Cited by 88
“(10) may serve as a novel mechanism underlying its anti-inflammatory actions.”
BackgroundInfluentialGamad, N., Malik, S., Suchal, K., Vasisht, S., Tomar, A., Arava, S. K., Arya, D. S., & Bhatia, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.101 · Cited by 89
Lee, M. K. S., Moore, X., Fu, Y., Al‐Sharea, A., Dragoljevic, D., Fernandez-Rojo, M. A., Parton, R. G., Sviridov, D., Murphy, A. J., & Chin-Dusting, J. P. F. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13319 · Cited by 85
“STAT3 has been previously shown to be induced upon inflammatory stimulation of macrophages with inflammatory mediators (Guo et al., 2014; Vasamsetti et al., 2015).”
BackgroundUnderstanding the action mechanisms of metformin in the gastrointestinal tract
Cheng, M., Ren, L., Jia, X., Wang, J., & Cong, B. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1347047 · Cited by 84
Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections
Shen, Y. H., & LeMaire, S. A. (2017) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2017.01.001 · Cited by 82
Zhong, X., Ma, X., Zhang, L., Li, Y., Li, Y., & He, R. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.052 · Cited by 81
Pharmacological targets of metabolism in disease: Opportunities from macrophages
Castegna, A., Gissi, R., Menga, A., Montopoli, M., Favia, M., Viola, A., & Canton, M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107521 · Cited by 81
From Mitochondria to Atherosclerosis: The Inflammation Path
Suarez-Rivero, J. M., Pastor‐Maldonado, C. J., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Talaverón-Rey, M., Suárez-Carrillo, A., Munuera-Cabeza, M., & Sánchez-Alcázar, J. A. (2021) · Biomedicines · doi:10.3390/biomedicines9030258 · Cited by 81
“The activation of AMPK has a high number of potential anti-atherosclerotic effects, including the reduction of inflammatory cell adhesion to blood vessel endothelium, lipid accumulation, and proliferation of inflammatory cells caused by oxidized lipids, as well as the stimulation of cellular antioxidant defenses, the…”
BackgroundZhang, Y., Li, D., Zhu, Z., Chen, S., Lu, M., Cao, P., Chen, T., Li, S., Xue, S., Zhang, Y., et al. (2022) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2022.06.010 · Cited by 81
A new perspective on metformin therapy in type 1 diabetes
on behalf of The REMOVAL Study Team, Livingstone, R., Boyle, J. G., & Petrie, J. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4364-6 · Cited by 81
“tion in vascular tissues [44] or improvement in aspects of endothelial function [31, 45].”
BackgroundPereira, F. V., de Melo, A. C. L., Low, J. S., de Castro, Í. A., Braga, T. T., de Almeida, D. C., de Lima, A. G. U. B., Hiyane, M. I., Corrêa-Costa, M., Andrade‐Oliveira, V., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25380 · Cited by 81
O-GlcNAcylation in immunity and inflammation: An intricate system (Review)
Yu, L. S., Xie, M.-Z., Men, L., & Du, J. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4238 · Cited by 81
Pei, C., Zhang, Y., Wang, P., Zhang, B., Fang, L., Liu, B., & Meng, S. (2019) · Phytotherapy Research · doi:10.1002/ptr.6217 · Cited by 80
“, 2015), inhibits PMA‐induced monocyte‐to‐ macrophage differentiation (Vasamsetti et al., 2015), and attenuates atherosclerosis by enhancing the anti‐atherogenic effects of high‐ density lipoproteins (Ma, Wang, Yang, An, & Zhu, 2017) and reducing atheroma‐inducing macrophages formation in ApoE (−/−) mice (Wang, Ma, Zh…”
BackgroundXu, J., Kitada, M., Ogura, Y., & Koya, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641852 · Cited by 79
Vazirpanah, N., Ottria, A., van der Linden, M., Wichers, C. G. K., Schuiveling, M., van Lochem, E. G., Phipps‐Green, A. J., Merriman, T. R., Zimmermann, M., Jansen, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214656 · Cited by 79
Maniar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 77
“Metformin prevents the differentiation of monocytes to macrophages[63], which may impede the availability of intracellular sites of survival of these bacteria.”
BackgroundMetformin improves salivary gland inflammation and hypofunction in murine Sjögren’s syndrome
Kim, J., Kim, S., Park, J., Hwang, S., Choi, J., Jung, K., Ryu, J., Lee, S.-Y., Kwok, S., Cho, M., et al. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1904-0 · Cited by 77
He, C., Li, H., Viollet, B., Zou, M., & Xie, Z. (2015) · Diabetes · doi:10.2337/db15-0107 · Cited by 77
“Consistent with our findings, AMPK was reported to inhibit monocyte-to-macrophage differentiation (45) and prevent the IL-6–stimulated inflammatory response by suppressing STAT3 phosphorylation (46).”
BackgroundStattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation
Leidgens, V., Proske, J., Rauer, L., Moeckel, S., Renner, K., Bogdahn, U., Riemenschneider, M. J., Proescholdt, M. A., Vollmann‐Zwerenz, A., Hau, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14159 · Cited by 77
“Effects of metformin on STAT3 have been described in non-malignant [43– 53] and malignant tissues [23, 24, 54–64], with mainly inhibitory effects of metformin on STAT3-phosphorylation [23, 24, 43, 46–64].”
Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome
Peng, X., Yang, T., Liu, G., Liu, H., Peng, Y., & He, L. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.025 · Cited by 77
Vasamsetti, S. B., Karnewar, S., Gopoju, R., Gollavilli, P. N., Narra, S. R., Kumar, J. M., & Kotamraju, S. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.05.003 · Cited by 76
Self-citationHsu, C., Su, Y., Chen, Y., Tsai, S., Chang, C. C., Li, S., Huang, P., Chen, J., & Lin, S. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0447-9 · Cited by 76
“demonstrated an attenuation of atheromatous plaque and AA formation in metformin treated ApoE(−/−) mice [11].”
BackgroundGolledge, J., Morris, D., Pinchbeck, J. L., Rowbotham, S. E., Jenkins, J. S., Bourke, M., Bourke, B. M., Norman, P. E., Jones, R., & Moxon, J. V. (2018) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2018.07.035 · Cited by 76
Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS‐010759
Pujalte‐Martin, M., Belaïd, A., Bost, S., Kahi, M., Peraldi, P., Rouleau, M., Mazure, N. M., & Bost, F. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13583 · Cited by 73
“However, in conditions such as obesity [59,60], atherosclerosis [61], and bone-associated pathologies [62] metformin induces M2 polarization.”
BackgroundEffects of imeglimin on mitochondrial function, AMPK activity, and gene expression in hepatocytes
Hozumi, K., Sugawara, K., Ishihara, T., Ishihara, N., & Ogawa, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-27689-y · Cited by 71
Zhang, M., Zhu, H., Ding, Y., Liu, Z., Cai, Z., & Zou, M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.779447 · Cited by 71
“However, whether the effects of metformin or AICAR are AMPK-dependent is not clear because compound C, an inhibitor of AMPK, was ineffective in promoting monocyte-to-macrophage differentiation in the absence of PMA (19).”
BackgroundInfluentialMechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response
Kaur, N., Guan, Y., Raja, R., Ruiz‐Velasco, A., & Liu, W. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.694864 · Cited by 70
“Notably, metformin also exhibits its anti-inflammatory effects by inhibiting NF-κB (Hattori et al., 2006), reducing CRP production from vessel walls (Li et al., 2009), and blocking monocyte differentiation into macrophages (Vasamsetti et al., 2015), irrespective of diabetic status.”
BackgroundSarkar, K., Bank, S., Chatterjee, A., Dutta, K., Das, A., Chakraborty, S., Paul, N., Sarkar, J., De, S., Ghosh, S., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02015-w · Cited by 69
van Vught, L. A., Scicluna, B. P., Hoogendijk, A. J., Wiewel, M. A., Klouwenberg, P. M. C. K., Cremer, O. L., Horn, J., Nürnberg, P., Bonten, M. J. M., Schultz, M. J., et al. (2016) · Critical Care · doi:10.1186/s13054-016-1429-8 · Cited by 69
Metadata
- Authors
- Vasamsetti, S. B., Karnewar, S., Kanugula, A. K., Thatipalli, A. R., Kumar, J. M., & Kotamraju, S.
- Affiliations
- Indian Institute of Chemical Technology (IN)
- Centre for Cellular and Molecular Biology (IN)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-12-31
- Volume
- 64
- Issue
- 6
- Pages
- 2028-2041
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2031565266
- Cited by
- 397
- References
- 32
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 32 · 2023: 42 · 2022: 38 · 2021: 63 · 2020: 45 · 2019: 35 · 2018: 37 · 2017: 25 · 2016: 25 · 2015: 12
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science and Engineering Research Board (F.NO.SR/SO/HS-110/2008)
- Council for Scientific and Industrial Research (EpiHeD-BSC-0118, SMiLE-CSC-0111)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- metformin, monocyte-to-macrophage differentiation, AMPK, STAT3 phosphorylation, atherosclerosis, angiotensin II, inflammatory cytokines, c-Jun N-terminal kinase, aortic aneurysm, ApoE-deficient mice, AICAR, macrophage polarization, inflammation
- MeSH terms
- Animals, Apolipoproteins E, Cell Differentiation, Macrophages, Male, Metformin, Monocytes, Polymethacrylic Acids, Mice, Knockout, Atherosclerosis, STAT3 Transcription Factor, Mice, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.